Close
Help
Need Help?



Pubmed and Open Access Visibility in Clinical Medicine Insights: Oncology

Posted Tue, Sep, 11,2012

Articles published in open access journals like Clinical Medicine Insights: Oncology are more visible and likely to receive more citations than articles published in restricted access journals.During August, Pubmed Central statistics showed that Libertas Academica has 1,468 papers available for anyone to download for free. These papers received 38,226 views, including 9,352 downloads. The most pop...

Continue Reading →

Pubmed and Open Access Visibility in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Posted Tue, Sep, 11,2012

Articles published in open access journals like Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine are more visible and likely to receive more citations than articles published in restricted access journals.During August, Pubmed Central statistics showed that Libertas Academica has 1,468 papers available for anyone to download for free. These papers received 38,226 views, ...

Continue Reading →

Clinical Medicine Insights: Oncology Now Uses Project Counter Analytics

Posted Thu, Sep, 06,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Clinical Medicine Insights: Oncology.One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal'...

Continue Reading →

Most read paper in Cell Communication Insights

Posted Thu, Sep, 06,2012

Cell Communication Insights is an open access journal, meaning all articles are available for anyone to download freely without restriction. Open access journals are renowned for having high levels of article visibility compared to traditional subscription journals.One good example of how open access journals can offer high visibility is 'The Evolution of Cell Communication: The Road not Taken...

Continue Reading →

Open Access Visibility Statistics for Immunotherapy Insights

Posted Thu, Sep, 06,2012

Articles published in open access journals like Immunotherapy Insights are likely to receive more citations and a higher level of visibility than articles published in restricted access journals.Libertas’ goal is to maximize visibility for all articles published in Immunotherapy Insights and articles in the journal have been viewed more than 9,474 times since 2008. In addition to this, artic...

Continue Reading →

Clinical Medicine Insights: Pathology Now Uses Project Counter Analytics

Posted Wed, Sep, 05,2012

Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Clinical Medicine Insights: Pathology.One of the ways we measure an article's visibility is the number of views and downloads it receives.  The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal'...

Continue Reading →

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
The submission and publishing process was a good experience.  During the last few weeks from the submission to publication I have worked with high quality staff.  In my opinion, the easy communication was the most important characteristic of Libertas and an important influence on the final quality of the article.  I definitely recommend the publisher to my co-workers.
Dr Reinhardt Pinzon (Universidad Tecnologica de Panama, Panama)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results